| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 07/03/1996 | CN1032212C Process for preparing N-protected alpha-L-aspartyl-L-methyl phenylalaninate |
| 07/02/1996 | US5532407 Adding l-aspartic acid or aqueous solution to side stream from production of alpha-l-aspartyl-l-phenylalanine methyl ester before or after mineral acid hydrolysis of side stream, adjusting ph of hydrolysis reaction mixture to 5-6 |
| 07/02/1996 | US5532366 Enzyme inhibitors |
| 07/02/1996 | US5532359 Fungicides |
| 07/02/1996 | US5532015 Drying wet crystals of l-aspartyl-l-phenylalanine methyl ester to adjust the water content |
| 06/29/1996 | CA2166246A1 Process of producing .alpha.-l-aspartyldipeptide amide derivatives |
| 06/28/1996 | CA2165228A1 Metal chelate forming peptides and use thereof |
| 06/27/1996 | WO1996019495A1 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission |
| 06/27/1996 | WO1996019494A1 Peptides having immunomodulatory activity |
| 06/27/1996 | WO1996019493A1 N-SUBSTITUTED GLYCINE DERIVATIVES AS INHIBITORS OF FACTOR Xa |
| 06/27/1996 | WO1996019492A1 Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |
| 06/27/1996 | WO1996019491A1 Heterocyclic keto arginine peptides as thrombin inhibitors |
| 06/27/1996 | WO1996019483A1 Low molecular weight bicyclic thrombin inhibitors |
| 06/27/1996 | WO1996019473A1 New derivatives of pyroglutaminic acid, preparation process and applications |
| 06/27/1996 | CA2208773A1 Heterocyclic keto arginine peptides as thrombin inhibitors |
| 06/27/1996 | CA2208772A1 Low molecular weight bicyclic thrombin inhibitors |
| 06/27/1996 | CA2207373A1 N-substituted glycine derivatives as inhibitors of factor xa |
| 06/27/1996 | CA2206778A1 Peptides having immunomodulatory activity |
| 06/26/1996 | EP0718307A2 Derivatives of 1-oxo-2-(phenylsulfonyl-amino)-pentylpiperidine, their preparation and therapeutic use |
| 06/26/1996 | EP0718306A1 Crystallization of alpha-L-aspartyl-L-phenylalanine methyl ester from aqueous solution |
| 06/26/1996 | EP0717751A1 Antibiotics 10381v, w, x, y, z1, z2, pre-b and t |
| 06/26/1996 | EP0717736A1 Polar-substituted hydrocarbons |
| 06/26/1996 | EP0717732A1 Polyamidic acid derivatives with antigastrin activity, a method for their preparation, and their pharmaceutical use |
| 06/26/1996 | EP0717731A1 Difluoro statone antiviral analogs |
| 06/25/1996 | US5530155 Crystallizing the amino acid by adding alkali to slurry, maintaining the ph at 3 to 8 |
| 06/25/1996 | US5530142 Process for the preparation of phosphorus-containing L-amino acids and their esters and N-derivatives |
| 06/25/1996 | US5530097 Human cancer inhibitory peptide amides |
| 06/25/1996 | US5529997 Administering for analgesic, hypotensive or diuretic effect or to treat congestive heart failure or irritable bowel syndrome |
| 06/25/1996 | US5529996 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 06/25/1996 | US5529995 Aminoacetylmercapto derivatives useful as inhibitors of enkephalinase and ACE |
| 06/24/1996 | CA2166032A1 1-oxo-2-(phenylsulfonylamino)pentylpiperidine; process for preparing them and their use as therapeutic agents |
| 06/20/1996 | WO1996018644A1 Aromatic heterocyclic derivatives as enzyme inhibitors |
| 06/20/1996 | WO1996018643A1 Tachykinin antagonists |
| 06/20/1996 | WO1996018627A1 Ahpba-containing tripeptide derivative |
| 06/20/1996 | CA2206400A1 Aromatic heterocyclic derivatives as enzyme inhibitors |
| 06/20/1996 | CA2204130A1 Tachykinin antagonists |
| 06/19/1996 | EP0716658A1 Glycosyl amides of 2-aminoacylamino-2-deoxy sugars |
| 06/19/1996 | EP0716609A1 METHODS AND COMPOSITIONS FOR STIMULATING AND INHIBITING TGF-$g(b) ACTIVITY |
| 06/19/1996 | EP0535192B1 Novel dna gyrase inhibitors, process for their manufacture and pharmaceutical preparations containing same |
| 06/19/1996 | CN1124964A Trifunctional antithrombin and antiplatelet peptides |
| 06/19/1996 | CN1032058C A homogeneous compsn. for forming a film of precious metal and the process of firing such a film onto a substrate |
| 06/18/1996 | US5527795 Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 06/18/1996 | US5527770 Immunotherapeutic agent derived from bacteria |
| 06/18/1996 | US5527689 Forming n-benzyloxycarbonyl-aspartyl-phenylalanine methyl ester in presence of protease and salt mixture |
| 06/18/1996 | US5527610 Comprising tetrapeptide or pentapeptide repeating units containing proline and glycine with optional alanine residues |
| 06/13/1996 | WO1996017942A1 Production of peptides using recombinant fusion protein constructs |
| 06/13/1996 | WO1996017861A1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase |
| 06/13/1996 | WO1996017860A1 New dipeptide p-amidinobenzylamides with n-terminal sulfonyl or aminosulfonyl radicals |
| 06/13/1996 | WO1996017838A1 Malonic acid based matrix metalloproteinase inhibitors |
| 06/13/1996 | DE4443390A1 Neue dipeptidische p-Amidinobenzylamide mit N-terminalen Sulfonyl- bzw. Aminosulfonylresten New dipeptide p-Amidinobenzylamide with N-terminal sulfonyl or Aminosulfonylresten |
| 06/13/1996 | CA2207874A1 Novel dipeptide p-amidinobenzylamides with n-terminal sulfonyl or aminosulfonyl radicals |
| 06/13/1996 | CA2206848A1 Production of peptides using recombinant fusion protein constructs |
| 06/13/1996 | CA2206665A1 Malonic acid based matrix metalloproteinase inhibitors |
| 06/13/1996 | CA2204144A1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase |
| 06/12/1996 | EP0716150A1 DNA primer and a method for screening DNAs |
| 06/12/1996 | EP0716086A1 Malonic acid based matrix metalloproteinase inhibitors |
| 06/12/1996 | EP0715619A1 Inhibitors of tnf-alpha secretion |
| 06/12/1996 | EP0715618A1 Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors |
| 06/12/1996 | EP0503044B1 Peptide compounds of laevorotatory amino acids and ring molecules, and therapeutical applications thereof |
| 06/11/1996 | US5525727 Brain-specific drug delivery |
| 06/11/1996 | US5525723 Inhibitors of angiotensin converting enzyme, neutral endopeptidase |
| 06/11/1996 | US5525628 Salts of a glutathione alkylester and anaminoacids |
| 06/11/1996 | US5525623 Compositions and methods for the treatment of immunomediated inflammatory disorders |
| 06/11/1996 | US5525503 Signal transduction via CD28 |
| 06/11/1996 | US5525492 Polymerase chain reaction of nucleic acids |
| 06/09/1996 | CA2137625A1 Process for the treatment of aspartame |
| 06/06/1996 | WO1996016982A2 Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof |
| 06/06/1996 | WO1996016981A2 Peptide compounds for prevention and/or treatment of no-mediated diseases |
| 06/06/1996 | WO1996016950A1 Hiv protease inhibitors |
| 06/06/1996 | WO1996016947A1 Novel 2,3-diketopiperazine derivative or salt thereof |
| 06/06/1996 | WO1996016671A1 New antithrombotic formulation, process for its manufacturing, and use thereof |
| 06/06/1996 | CA2206459A1 New antithrombotic formulation, process for its manufacturing, and use thereof |
| 06/06/1996 | CA2206053A1 Novel 2,3-diketopiperazine derivatives or their salts |
| 06/06/1996 | CA2164402A1 Dna primer and a method for screening dnas |
| 06/05/1996 | EP0714903A1 New carbohydrate conjugates as cell adhesion inhibitors |
| 06/05/1996 | EP0669935B1 Compounds useful as sweetening agents and process for their preparation |
| 06/05/1996 | EP0577705B1 Method of enzymatic preparation of macrolactone |
| 06/05/1996 | CN1124012A Arylating medicaments |
| 06/05/1996 | CN1031948C Process for preparing antibiotic GE2270 |
| 06/04/1996 | US5523469 Reacting alkali metal sulfite on 1-(1-bromoethyl)-3-nitrobenzene; conversion to potassium salt; conversion to benzylquinium salt; then quaternization |
| 06/04/1996 | US5523456 Anticarcinogenic agents |
| 06/04/1996 | US5523313 Hypotensive agents; cardiotonic agents; inhibitors of neutral metalloendopeptidases; vasodilation; heart failure and renal insufficiency |
| 06/04/1996 | US5523308 Peptidyl heterocycles useful in the treatment of thrombin related disorders |
| 06/04/1996 | US5523289 Renin inhibitor |
| 05/30/1996 | WO1996016080A1 Human neutrophil elastase inhibitors |
| 05/30/1996 | WO1996016079A2 Alpha-ketoamide derivatives as cathepsin l inhibitor |
| 05/30/1996 | WO1996016078A1 Method of making a library of compounds |
| 05/30/1996 | WO1996016027A1 Matrix metalloprotease inhibitors |
| 05/30/1996 | WO1996015797A1 Pharmaceutical compositions comprising nitric oxide-releasing biopolymers |
| 05/30/1996 | CA2205583A1 Method of making a library of compounds |
| 05/30/1996 | CA2200964A1 Alpha-ketoamide derivatives as cathepsin l inhibitor |
| 05/29/1996 | EP0713865A1 2-Aminobenzenesulphonic acid and 2-aminobenzenesulphonyl chloride derivatives, their preparation and their use as synthetic intermediates |
| 05/29/1996 | EP0713859A2 Cinnamic acid derivatives, photocrosslinkable cinnamic acid-polymer derivative and crosslinked cinnamic acid polymer derivatives |
| 05/29/1996 | EP0713495A1 Methods of enhancing bioactivity of chemokines |
| 05/29/1996 | EP0471809B1 Method for preparing n-protected (2s,3s)-3-ethylaspartic acid dialkyl esters |
| 05/29/1996 | CN1031880C Process for preparing novel analogs of peptidase substrates |
| 05/28/1996 | US5521284 Human cancer inhibitory pentapeptide amides and esters |
| 05/28/1996 | US5521179 Heterocyclic amides |
| 05/28/1996 | US5521159 Partially modified and retro-inverted tetrapeptides analogues of C-reactive protein fragments |
| 05/23/1996 | WO1996015148A2 Low molecular weight peptidomimetic growth hormone secretagogues |